DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

InvestmentUpdated on 28 April 2026

Accelerate preclinical and clinical development

Nicolás Galmarini

CEO & Co-founder at NanoVet Biotech

Pamplona, Spain

About

NanoVet is seeking investment to accelerate the preclinical and clinical development of its lead programs and to expand its nanobody platform into additional animal health indications. Capital will support regulatory advancement, pipeline expansion, and manufacturing readiness, with a strong value proposition based on first-in-class nanobody applications in veterinary medicine and a scalable platform with translational potential into human therapeutics.

Similar opportunities